Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 15, 2019

SELL
$5.51 - $9.59 $67,960 - $118,283
-12,334 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$5.55 - $11.34 $68,453 - $139,867
12,334 New
12,334 $69,000
Q3 2018

Nov 14, 2018

SELL
$9.74 - $12.92 $288,946 - $383,284
-29,666 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$10.16 - $13.65 $301,406 - $404,940
29,666 New
29,666 $303,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $31M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.